Safety of Chromax Chromium Picolinate reinforced by new study
The study was conducted at the request of the United Kingdom (UK) Food Standards Agency (FSA) to repeat a previously published study showing DNA damage.
27/06/05 Nutrition 21, Inc. has announced results of a new study reaffirming the safety of Chromax chromium picolinate to be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis, the leading peer-reviewed genotoxicity journal said.
The results found that Chromax did not cause genetic damage in hamster ovary cells. The study was conducted at the request of the United Kingdom (UK) Food Standards Agency (FSA) to repeat a previously published study showing DNA damage. The prior study was not performed under International Conference on Harmonization (ICH) Guidelines and did not use commercially available chromium picolinate.
The body of scientific evidence supporting chromium picolinate's safety includes more than 50 studies, including human clinical trials with more than 2,000 participants, numerous animal studies on thousands of animals, and cellular testing. Chromium picolinate has been recognized as safe by many of the world's leading government and private research institutions including the UK FSA and the Institute of Medicine.
Chromium is an essential trace mineral critical to proper insulin function and necessary for carbohydrate, fat and protein metabolism. Chromium, which is found naturally in foods in small amounts, is not well absorbed by the body. Chromium, in the form of chromium picolinate, has been used as a supplement ingredient for more than a decade in leading U.S. vitamin brands. An estimated 10 million people consume supplements with chromium each year. Safety research conducted over the past several years has confirmed no significant adverse effects of chromium picolinate when ingested at any dose.
